167 related articles for article (PubMed ID: 34287678)
41. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
Gershenson DM
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
[TBL] [Abstract][Full Text] [Related]
42. Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes.
Bergamini A; Luisa FM; Dellino M; Erica S; Loizzi V; Bocciolone L; Rabaiotti E; Cioffi R; Sabetta G; Cormio G; Mangili G
Int J Gynecol Cancer; 2022 Aug; 32(8):1063-1070. PubMed ID: 35437273
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience.
Elashry R; Hemida R; Goda H; Abdel-Hady el-S
J Exp Ther Oncol; 2013; 10(3):181-7. PubMed ID: 24416992
[TBL] [Abstract][Full Text] [Related]
44. [Update on malignant nonepithelial ovarian tumours].
Bats AS; Larousserie F; Le Frère Belda MA; Metzger U; Lécuru F
Gynecol Obstet Fertil; 2009; 37(7-8):627-32. PubMed ID: 19574079
[TBL] [Abstract][Full Text] [Related]
45. [Preservation of the fertility and the ovaries in women with benign adnexal tumors].
Souza E; Yoshida A; Peres H; Andrade Lde A; Sarian LO; Derchain S
Rev Bras Ginecol Obstet; 2015 Jan; 37(1):36-41. PubMed ID: 25607128
[TBL] [Abstract][Full Text] [Related]
46. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
[TBL] [Abstract][Full Text] [Related]
47. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
Li J; Wu X
Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
[TBL] [Abstract][Full Text] [Related]
48. Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant-a Chinese retrospective cohort study among 148 cases.
Yang B; Yu Y; Chen J; Zhang Y; Yin Y; Yu N; Chen G; Zhu S; Huang H; Yuan Y; Ai J; Wang X; Li K
Front Med; 2018 Oct; 12(5):509-517. PubMed ID: 29218679
[TBL] [Abstract][Full Text] [Related]
49. Gonadoblastoma versus ovarian mixed germ cell-sex cord stromal tumor in women or girls with no evidence of a disorder of sex development: A problem in differential diagnosis.
Roth LM; Czernobilsky B; Mann SA; Cheng L
Pathol Res Pract; 2020 Nov; 216(11):153198. PubMed ID: 33002849
[TBL] [Abstract][Full Text] [Related]
50. Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
Roth LM; Lyu B; Cheng L
Hum Pathol; 2017 Jul; 65():1-14. PubMed ID: 28445692
[TBL] [Abstract][Full Text] [Related]
51. Fertility sparing surgery for ovarian tumors in children and young adults.
Abdel-Hady el-S; Abdel-Hady Hemida R; Gamal A; El-Shamey M
Arch Gynecol Obstet; 2012 Feb; 285(2):469-71. PubMed ID: 21701836
[TBL] [Abstract][Full Text] [Related]
52. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
[TBL] [Abstract][Full Text] [Related]
53. Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
Tamauchi S; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
Am J Obstet Gynecol; 2018 Oct; 219(4):385.e1-385.e7. PubMed ID: 30086295
[TBL] [Abstract][Full Text] [Related]
54. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
[TBL] [Abstract][Full Text] [Related]
55. Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study.
Chen J; Wang FF; Zhang Y; Yang B; Ai JH; Wang XY; Cheng XD; Li KZ
Curr Med Sci; 2020 Aug; 40(4):745-752. PubMed ID: 32862386
[TBL] [Abstract][Full Text] [Related]
56. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
[TBL] [Abstract][Full Text] [Related]
57. Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies.
Muzii L; Palaia I; Sansone M; Calcagno M; Plotti F; Angioli R; Panici PB
Fertil Steril; 2009 Jun; 91(6):2632-7. PubMed ID: 18555237
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
59. Mixed germ cell-sex cord stromal tumour of the testis and ovary: comparison and contrast.
Roth LM; Cheng L
Pathology; 2021 Feb; 53(2):166-169. PubMed ID: 33358757
[TBL] [Abstract][Full Text] [Related]
60. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
Melamed A; Rizzo AE; Nitecki R; Gockley AA; Bregar AJ; Schorge JO; Del Carmen MG; Rauh-Hain JA
Obstet Gynecol; 2017 Jul; 130(1):71-79. PubMed ID: 28594773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]